SPL026 Small Pharma (DMT.V), a psychedelics company focusing on DMT announced today it’s completed Phase 1 for its drug candidate SPL026, (a DMT derivative) for the treatment of Major…
dmt.v
SPL026 Small Pharma (DMT.V) is a London-based psychedelics company focusing on DMT-assisted psychotherapy for depression, and they’re already doing Phase 1 clinical trials, with Phase 2 on the…